» Articles » PMID: 33343381

New Insights Into Implications of CTRP3 in Obesity, Metabolic Dysfunction, and Cardiovascular Diseases: Potential of Therapeutic Interventions

Overview
Journal Front Physiol
Date 2020 Dec 21
PMID 33343381
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Adipose tissue, as the largest endocrine organ, secretes many biologically active molecules circulating in the bloodstream, collectively termed adipocytokines, which not only regulate the metabolism but also play a role in pathophysiological processes. C1q tumor necrosis factor (TNF)-related protein 3 (CTRP3) is a member of C1q tumor necrosis factor-related proteins (CTRPs), which is a paralog of adiponectin. CTRP3 has a wide range of effects on glucose/lipid metabolism, inflammation, and contributes to cardiovascular protection. In this review, we comprehensively discussed the latest research on CTRP3 in obesity, diabetes, metabolic syndrome, and cardiovascular diseases.

Citing Articles

Mechanism of KDM4A in Regulating Microglial Polarization in Ischemic Stroke.

Du J, Liang X, Wang D, Wang Z, Shen R Appl Biochem Biotechnol. 2025; .

PMID: 40080374 DOI: 10.1007/s12010-025-05207-2.


Decreased Serum CTRP3 level was associated with connective tissue diseases.

Ma L, Lin J, Shao M, Chen B, Zhou R, Shi J Heliyon. 2024; 10(16):e36322.

PMID: 39253249 PMC: 11382063. DOI: 10.1016/j.heliyon.2024.e36322.


Relation between serum sclerostin and CTRP3 levels and bone mineral density in diabetic postmenopausal women.

Ahmad I, Elhamed Gbr S, Ali El Naggar B, Abdelwahab M, El-Saghier E, Sayed Mohammed D BMC Womens Health. 2024; 24(1):490.

PMID: 39237913 PMC: 11375883. DOI: 10.1186/s12905-024-03311-9.


Effects of silymarin as adjuvant drug on serum levels of CTRP3, anti-cyclic citrullinated peptide (CCP), and high-sensitivity C-reactive protein (hs-CRP) in rheumatoid arthritis patients.

Elahi M, Elieh-Ali-Komi D, Goudarzi F, Mohammadi Noori E, Assar S, Shavandi M Mol Biol Res Commun. 2024; 13(3):137-145.

PMID: 38915456 PMC: 11194032. DOI: 10.22099/mbrc.2024.48466.1876.


Decreased circulating CTRP3 levels in acute and chronic cardiovascular patients.

Schmid A, Pankuweit S, Vlacil A, Koch S, Berge B, Gajawada P J Mol Med (Berl). 2024; 102(5):667-677.

PMID: 38436713 PMC: 11055757. DOI: 10.1007/s00109-024-02426-8.


References
1.
Song Y, Mai H, Lin Y, Wang Y, Wang X, Gu S . MiR-144 affects proliferation and apoptosis of high glucose-induced AC16 cardiomyocytes by regulating CTRP3/JNK signaling. Int J Clin Exp Pathol. 2020; 13(2):142-152. PMC: 7061800. View

2.
Cho N, Shaw J, Karuranga S, Huang Y, da Rocha Fernandes J, Ohlrogge A . IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018; 138:271-281. DOI: 10.1016/j.diabres.2018.02.023. View

3.
Zhang B, Zhang P, Tan Y, Feng P, Zhang Z, Liang H . C1q-TNF-related protein-3 attenuates pressure overload-induced cardiac hypertrophy by suppressing the p38/CREB pathway and p38-induced ER stress. Cell Death Dis. 2019; 10(7):520. PMC: 6614451. DOI: 10.1038/s41419-019-1749-0. View

4.
Donath M, Shoelson S . Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011; 11(2):98-107. DOI: 10.1038/nri2925. View

5.
Zhang J, Zhang B, Cheng Y, Xu J . Low serum CTRP3 levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Cytokine. 2017; 106:131-135. DOI: 10.1016/j.cyto.2017.10.023. View